Apellis(APLS) - 2023 Q4 - Earnings Call Transcript

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 Full Year 2023 Earnings Conference Call February 27, 2024 8:30 AM ET Company Participants Cedric Francois - Co-Founder and Chief Executive Officer Tim Sullivan - Chief Financial Officer Adam Townsend - Chief Operating Officer Caroline Baumal - Chief Medical Officer Meredith Kaya - SVP of Investor Relations and Strategic Finance Conference Call Participants Jonathan Miller - Evercore Tazeen Ahmad - Bank of America Anupam Rama - J.P. Morgan Yigal Nochomovitz - C ...